Evan Levine, CEO & President at ADVENTRX PHARMACEUTICALS INC (ANX), bought 24,300 shares at $0.43 ($39K) on 2008-02-05, disclosed to the SEC on 2008-04-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.19 | 700 | $833 | 2.1% |
| 2 | $1.19 | 2,300 | $3K | 7.0% |
| 3 | $0.93 | 100 | $93 | 0.2% |
| 4 | $0.93 | 400 | $372 | 0.9% |
| 5 | $0.93 | 500 | $465 | 1.2% |
| 6 | $0.93 | 1,500 |
| $1K |
| 3.6% |
| 7 | $0.86 | 1,800 | $2K | 4.0% |
| 8 | $3.86 | 100 | $386 | 1.0% |
| 9 | $3.86 | 900 | $3K | 8.9% |
| 10 | $3.87 | 1,000 | $4K | 9.9% |
| 11 | $5.15 | 1,000 | $5K | 13.2% |
| 12 | $4.47 | 1,000 | $4K | 11.4% |
| 13 | $4.36 | 1,000 | $4K | 11.1% |
| 14 | $3.15 | 1,000 | $3K | 8.0% |
| 15 | $2.63 | 1,000 | $3K | 6.7% |
| 16 | $0.42 | 5,000 | $2K | 5.4% |
| 17 | $0.42 | 2,000 | $840 | 2.1% |
| 18 | $0.43 | 3,000 | $1K | 3.3% |
| Total | $1.61 avg | 24,300 | $39K | 100% |
| Filing → |
| ANX | BUY | 2007-12-17 | $27K | — | Filing → |
| QTXB | SELL | 2007-02-09 | $559K | — | Filing → |